

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.05884162 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.84318883 |
| 3 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.95686011 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.74107527 |
| 5 | histamine secretion (GO:0001821) | 3.70956556 |
| 6 | detection of other organism (GO:0098543) | 3.70161066 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.61252571 |
| 8 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.54727281 |
| 9 | neutrophil activation (GO:0042119) | 3.51360082 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.48202134 |
| 11 | respiratory burst (GO:0045730) | 3.40985474 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.38335573 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 3.32027766 |
| 14 | granulocyte activation (GO:0036230) | 3.31037997 |
| 15 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.29078676 |
| 16 | neutrophil mediated immunity (GO:0002446) | 3.28236529 |
| 17 | protein neddylation (GO:0045116) | 3.26879509 |
| 18 | negative regulation of interleukin-17 production (GO:0032700) | 3.25696394 |
| 19 | phagosome maturation (GO:0090382) | 3.24091957 |
| 20 | leukocyte aggregation (GO:0070486) | 3.22834703 |
| 21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.18754285 |
| 22 | detection of bacterium (GO:0016045) | 3.16248037 |
| 23 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.13609020 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.11952940 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.06297439 |
| 26 | protein localization to endosome (GO:0036010) | 3.05360359 |
| 27 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.01000337 |
| 28 | ATP synthesis coupled proton transport (GO:0015986) | 3.01000337 |
| 29 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.99985126 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 2.98061057 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 2.98061057 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.98061057 |
| 33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.98061057 |
| 34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.98061057 |
| 35 | modulation by symbiont of host immune response (GO:0052553) | 2.98061057 |
| 36 | myeloid leukocyte mediated immunity (GO:0002444) | 2.95960981 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 2.94355594 |
| 38 | negative regulation of cell killing (GO:0031342) | 2.91899421 |
| 39 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.91899421 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.91784948 |
| 41 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.91784948 |
| 42 | detection of external biotic stimulus (GO:0098581) | 2.89736862 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 2.88144901 |
| 44 | signal peptide processing (GO:0006465) | 2.86986141 |
| 45 | negative regulation of protein autophosphorylation (GO:0031953) | 2.84506231 |
| 46 | platelet dense granule organization (GO:0060155) | 2.84146886 |
| 47 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.83914531 |
| 48 | activated T cell proliferation (GO:0050798) | 2.83821764 |
| 49 | thrombin receptor signaling pathway (GO:0070493) | 2.83005358 |
| 50 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.82654149 |
| 51 | myeloid cell activation involved in immune response (GO:0002275) | 2.82072139 |
| 52 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.81322256 |
| 53 | Rap protein signal transduction (GO:0032486) | 2.78823790 |
| 54 | mast cell activation (GO:0045576) | 2.77063448 |
| 55 | actin nucleation (GO:0045010) | 2.75550673 |
| 56 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.74509349 |
| 57 | response to peptidoglycan (GO:0032494) | 2.71388597 |
| 58 | sequestering of actin monomers (GO:0042989) | 2.69600709 |
| 59 | leukocyte degranulation (GO:0043299) | 2.68613895 |
| 60 | T cell migration (GO:0072678) | 2.68525998 |
| 61 | interferon-gamma production (GO:0032609) | 2.68403379 |
| 62 | regulation of tolerance induction (GO:0002643) | 2.67140488 |
| 63 | myeloid dendritic cell activation (GO:0001773) | 2.67105528 |
| 64 | regulation of B cell differentiation (GO:0045577) | 2.66255082 |
| 65 | positive regulation of mast cell activation (GO:0033005) | 2.62780763 |
| 66 | macrophage activation (GO:0042116) | 2.61669109 |
| 67 | negative regulation of T cell mediated immunity (GO:0002710) | 2.60469859 |
| 68 | histamine transport (GO:0051608) | 2.60407467 |
| 69 | microglial cell activation (GO:0001774) | 2.60212434 |
| 70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.60080004 |
| 71 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.59631727 |
| 72 | regulation of mast cell activation (GO:0033003) | 2.58607233 |
| 73 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.57705360 |
| 74 | positive regulation of leukocyte degranulation (GO:0043302) | 2.56737922 |
| 75 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.54647026 |
| 76 | positive regulation of macrophage differentiation (GO:0045651) | 2.53889389 |
| 77 | myeloid dendritic cell differentiation (GO:0043011) | 2.53711404 |
| 78 | regulation of monocyte chemotaxis (GO:0090025) | 2.52464161 |
| 79 | B cell receptor signaling pathway (GO:0050853) | 2.51160114 |
| 80 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.50945337 |
| 81 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.50488763 |
| 82 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.50154835 |
| 83 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.49914038 |
| 84 | * dendritic cell migration (GO:0036336) | 2.49148620 |
| 85 | eosinophil chemotaxis (GO:0048245) | 2.49048482 |
| 86 | response to interleukin-15 (GO:0070672) | 2.49006380 |
| 87 | hepatocyte apoptotic process (GO:0097284) | 2.48412521 |
| 88 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.48081590 |
| 89 | positive regulation of antigen processing and presentation (GO:0002579) | 2.47214035 |
| 90 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.47204307 |
| 91 | response to nerve growth factor (GO:1990089) | 2.47204307 |
| 92 | regulation of interleukin-17 production (GO:0032660) | 2.46888514 |
| 93 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.46028184 |
| 94 | positive regulation of interferon-alpha production (GO:0032727) | 2.45317742 |
| 95 | membrane raft organization (GO:0031579) | 2.44910216 |
| 96 | oligosaccharide catabolic process (GO:0009313) | 2.44788481 |
| 97 | regulation of mast cell degranulation (GO:0043304) | 2.42722665 |
| 98 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.42246414 |
| 99 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.42201977 |
| 100 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.41444749 |
| 101 | tolerance induction (GO:0002507) | 2.41323881 |
| 102 | detection of biotic stimulus (GO:0009595) | 2.40956837 |
| 103 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.40462842 |
| 104 | response to host immune response (GO:0052572) | 2.40462842 |
| 105 | neutrophil chemotaxis (GO:0030593) | 2.40064332 |
| 106 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.40035956 |
| 107 | positive regulation of actin filament polymerization (GO:0030838) | 2.39962714 |
| 108 | myeloid leukocyte activation (GO:0002274) | 2.39434554 |
| 109 | transferrin transport (GO:0033572) | 2.38934553 |
| 110 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.38550017 |
| 111 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.38550017 |
| 112 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.38450597 |
| 113 | negative regulation of type 2 immune response (GO:0002829) | 2.37503092 |
| 114 | leukocyte mediated cytotoxicity (GO:0001909) | 2.37469967 |
| 115 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.37405205 |
| 116 | regulation of T cell migration (GO:2000404) | 2.37132719 |
| 117 | amino sugar catabolic process (GO:0046348) | 2.36796945 |
| 118 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.35466006 |
| 119 | cellular response to interferon-beta (GO:0035458) | 2.35329211 |
| 120 | regulation of T cell tolerance induction (GO:0002664) | 2.35227938 |
| 121 | neutrophil migration (GO:1990266) | 2.34942266 |
| 122 | negative regulation of microtubule polymerization (GO:0031115) | 2.34916387 |
| 123 | cellular defense response (GO:0006968) | 2.34561812 |
| 124 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.34109503 |
| 125 | regulation of interferon-alpha production (GO:0032647) | 2.33890986 |
| 126 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.33576700 |
| 127 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.33576700 |
| 128 | regulation of lymphocyte migration (GO:2000401) | 2.33449047 |
| 129 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.33345260 |
| 130 | positive regulation of lamellipodium assembly (GO:0010592) | 2.33170897 |
| 131 | superoxide anion generation (GO:0042554) | 2.32598188 |
| 132 | response to interferon-beta (GO:0035456) | 2.32475011 |
| 133 | negative regulation of mast cell activation (GO:0033004) | 2.32346648 |
| 134 | cellular response to zinc ion (GO:0071294) | 2.31884898 |
| 135 | positive regulation of T cell migration (GO:2000406) | 2.30481624 |
| 136 | neural tube formation (GO:0001841) | 2.30359890 |
| 137 | cellular extravasation (GO:0045123) | 2.30029438 |
| 138 | positive regulation of tolerance induction (GO:0002645) | 2.29679918 |
| 139 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.29542649 |
| 140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.29380167 |
| 141 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.29293304 |
| 142 | positive regulation of mast cell degranulation (GO:0043306) | 2.29293304 |
| 143 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.28668405 |
| 144 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.28649752 |
| 145 | positive regulation of B cell differentiation (GO:0045579) | 2.28555822 |
| 146 | granulocyte chemotaxis (GO:0071621) | 2.28544927 |
| 147 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.27937285 |
| 148 | negative regulation of ligase activity (GO:0051352) | 2.27937285 |
| 149 | positive regulation of regulated secretory pathway (GO:1903307) | 2.27800402 |
| 150 | positive regulation of T cell chemotaxis (GO:0010820) | 2.27561995 |
| 151 | regulation of T cell chemotaxis (GO:0010819) | 2.27561995 |
| 152 | eosinophil migration (GO:0072677) | 2.27095676 |
| 153 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.26985202 |
| 154 | macrophage activation involved in immune response (GO:0002281) | 2.26963738 |
| 155 | cellular response to interleukin-15 (GO:0071350) | 2.26924657 |
| 156 | positive regulation of actin filament depolymerization (GO:0030836) | 2.26377025 |
| 157 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.26258810 |
| 158 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.25992110 |
| 159 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.25992110 |
| 160 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.25992110 |
| 161 | T-helper 1 type immune response (GO:0042088) | 2.24582048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.45977240 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.38912018 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.34473135 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.32337655 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.43214017 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21705228 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.08528256 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.98982851 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.97010739 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.88886374 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75573918 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.67866848 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.62476358 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.62338100 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58063396 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.43723499 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.42743282 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.41828497 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.41773054 |
| 20 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40575637 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.37048356 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.20167019 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.18006041 |
| 24 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.08485056 |
| 25 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.01322721 |
| 26 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.00333488 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95398303 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.91397902 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90270691 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.89198600 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.87473973 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.81930248 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81655232 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.81246310 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78075771 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.76670669 |
| 37 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.63745407 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.56755691 |
| 39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.55337522 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.54494487 |
| 41 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.54003283 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53817581 |
| 43 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.52313056 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51486556 |
| 45 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.47409327 |
| 46 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46715304 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46563205 |
| 48 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.45331459 |
| 49 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.45244876 |
| 50 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.44579768 |
| 51 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.44323822 |
| 52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.43973370 |
| 53 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.43670334 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43263430 |
| 55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39545641 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.38934506 |
| 57 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.38406915 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36980257 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.35401072 |
| 60 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.32431556 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31453927 |
| 62 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.30690430 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28619595 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28304379 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25687118 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25623391 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24862505 |
| 68 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.24697857 |
| 69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24477314 |
| 70 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.23786426 |
| 71 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.23732340 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23404164 |
| 73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.22465258 |
| 74 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.21586725 |
| 75 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20264102 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19876313 |
| 77 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19860585 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18075761 |
| 79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17363796 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17313047 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16826459 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.16419309 |
| 83 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.16274296 |
| 84 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13657179 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12757717 |
| 86 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.11324782 |
| 87 | VDR_22108803_ChIP-Seq_LS180_Human | 1.11295676 |
| 88 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11139746 |
| 89 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.11079024 |
| 90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11029845 |
| 91 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.10687503 |
| 92 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10531231 |
| 93 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10219596 |
| 94 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.09943059 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09835089 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09021233 |
| 97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09021233 |
| 98 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08095155 |
| 99 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07796856 |
| 100 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.07298383 |
| 101 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.07285948 |
| 102 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07067125 |
| 103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06584370 |
| 104 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.06251367 |
| 105 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05986870 |
| 106 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05731134 |
| 107 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.04293495 |
| 108 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.04285601 |
| 109 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04092241 |
| 110 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03415962 |
| 111 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03118816 |
| 112 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02014028 |
| 113 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02008554 |
| 114 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01320753 |
| 115 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00554956 |
| 116 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00409751 |
| 117 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00248704 |
| 118 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.99715803 |
| 119 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99514381 |
| 120 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99119582 |
| 121 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99018122 |
| 122 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98988145 |
| 123 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98778914 |
| 124 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.98650269 |
| 125 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98331822 |
| 126 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.97903286 |
| 127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97840536 |
| 128 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97668701 |
| 129 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97324750 |
| 130 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.97098083 |
| 131 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.96682128 |
| 132 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96597949 |
| 133 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.96504260 |
| 134 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96377190 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95791808 |
| 136 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95528461 |
| 137 | * MYB_26560356_Chip-Seq_TH1_Human | 0.94388918 |
| 138 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93667260 |
| 139 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.93664787 |
| 140 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92361299 |
| 141 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92322566 |
| 142 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91684503 |
| 143 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.91220922 |
| 144 | P300_19829295_ChIP-Seq_ESCs_Human | 0.91133815 |
| 145 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90128133 |
| 146 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.88284163 |
| 147 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87500938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.05361507 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.50388675 |
| 3 | MP0009785_altered_susceptibility_to | 3.44053023 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.36156663 |
| 5 | MP0005671_abnormal_response_to | 3.23935318 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.84552679 |
| 7 | MP0003436_decreased_susceptibility_to | 2.78994963 |
| 8 | MP0002419_abnormal_innate_immunity | 2.61585496 |
| 9 | MP0006082_CNS_inflammation | 2.49312784 |
| 10 | MP0005025_abnormal_response_to | 2.46179547 |
| 11 | MP0003724_increased_susceptibility_to | 2.45214612 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.40791523 |
| 13 | MP0001790_abnormal_immune_system | 2.35023501 |
| 14 | MP0005387_immune_system_phenotype | 2.35023501 |
| 15 | MP0000685_abnormal_immune_system | 2.34272845 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.27924171 |
| 17 | MP0001819_abnormal_immune_cell | 2.27602660 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.24001626 |
| 19 | MP0002723_abnormal_immune_serum | 2.23385246 |
| 20 | MP0001800_abnormal_humoral_immune | 2.20353453 |
| 21 | MP0003828_pulmonary_edema | 2.10720270 |
| 22 | MP0003303_peritoneal_inflammation | 2.01081366 |
| 23 | MP0005248_abnormal_Harderian_gland | 1.99019530 |
| 24 | MP0006054_spinal_hemorrhage | 1.94167481 |
| 25 | MP0002006_tumorigenesis | 1.89501806 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.86514980 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.84721663 |
| 28 | MP0000343_altered_response_to | 1.79937678 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.78053013 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.76435105 |
| 31 | MP0003448_altered_tumor_morphology | 1.74997385 |
| 32 | MP0003880_abnormal_central_pattern | 1.71974519 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.71903708 |
| 34 | MP0002405_respiratory_system_inflammati | 1.69331116 |
| 35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.64720406 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.61818934 |
| 37 | MP0000716_abnormal_immune_system | 1.59900833 |
| 38 | MP0002398_abnormal_bone_marrow | 1.58264319 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.51414924 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.50665464 |
| 41 | MP0008438_abnormal_cutaneous_collagen | 1.45995250 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.43714582 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.41657391 |
| 44 | MP0002933_joint_inflammation | 1.37382359 |
| 45 | MP0001879_abnormal_lymphatic_vessel | 1.37349383 |
| 46 | MP0002163_abnormal_gland_morphology | 1.35173679 |
| 47 | MP0004484_altered_response_of | 1.34275581 |
| 48 | MP0001905_abnormal_dopamine_level | 1.31164713 |
| 49 | MP0002102_abnormal_ear_morphology | 1.30317551 |
| 50 | MP0005310_abnormal_salivary_gland | 1.30239493 |
| 51 | MP0000858_altered_metastatic_potential | 1.30130369 |
| 52 | MP0000372_irregular_coat_pigmentation | 1.29281423 |
| 53 | MP0002429_abnormal_blood_cell | 1.27770831 |
| 54 | MP0001853_heart_inflammation | 1.27747897 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.25040124 |
| 56 | MP0005164_abnormal_response_to | 1.24846205 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.24144307 |
| 58 | MP0001542_abnormal_bone_strength | 1.22956745 |
| 59 | MP0000604_amyloidosis | 1.20585929 |
| 60 | MP0004510_myositis | 1.19704228 |
| 61 | MP0004883_abnormal_blood_vessel | 1.19359272 |
| 62 | MP0000920_abnormal_myelination | 1.19312323 |
| 63 | MP0001529_abnormal_vocalization | 1.19109683 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.18898826 |
| 65 | MP0002722_abnormal_immune_system | 1.17928214 |
| 66 | MP0001851_eye_inflammation | 1.16967987 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.15699818 |
| 68 | MP0010678_abnormal_skin_adnexa | 1.14097003 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 1.14055395 |
| 70 | MP0010155_abnormal_intestine_physiology | 1.11688121 |
| 71 | MP0010386_abnormal_urinary_bladder | 1.06644675 |
| 72 | MP0005174_abnormal_tail_pigmentation | 1.05632156 |
| 73 | MP0002009_preneoplasia | 1.03700557 |
| 74 | MP0003195_calcinosis | 1.02784322 |
| 75 | MP0001958_emphysema | 1.02239505 |
| 76 | MP0004947_skin_inflammation | 1.01045536 |
| 77 | MP0002909_abnormal_adrenal_gland | 1.00191233 |
| 78 | MP0005166_decreased_susceptibility_to | 0.98414063 |
| 79 | MP0002998_abnormal_bone_remodeling | 0.98005491 |
| 80 | MP0003866_abnormal_defecation | 0.96517025 |
| 81 | MP0000569_abnormal_digit_pigmentation | 0.95441048 |
| 82 | MP0008260_abnormal_autophagy | 0.95091621 |
| 83 | MP0002928_abnormal_bile_duct | 0.94500548 |
| 84 | MP0008469_abnormal_protein_level | 0.93562462 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.91539371 |
| 86 | MP0001873_stomach_inflammation | 0.90257973 |
| 87 | MP0009379_abnormal_foot_pigmentation | 0.90091501 |
| 88 | MP0005390_skeleton_phenotype | 0.87975212 |
| 89 | MP0005171_absent_coat_pigmentation | 0.87782449 |
| 90 | MP0003300_gastrointestinal_ulcer | 0.86009509 |
| 91 | MP0002277_abnormal_respiratory_mucosa | 0.85856408 |
| 92 | MP0001915_intracranial_hemorrhage | 0.84135463 |
| 93 | MP0002736_abnormal_nociception_after | 0.84046277 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.82724581 |
| 95 | MP0000249_abnormal_blood_vessel | 0.79687350 |
| 96 | MP0009840_abnormal_foam_cell | 0.79535775 |
| 97 | MP0005165_increased_susceptibility_to | 0.79376707 |
| 98 | MP0009763_increased_sensitivity_to | 0.78516168 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.77527672 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.77136564 |
| 101 | MP0000703_abnormal_thymus_morphology | 0.76821721 |
| 102 | MP0004272_abnormal_basement_membrane | 0.76410670 |
| 103 | MP0001968_abnormal_touch/_nociception | 0.76165482 |
| 104 | MP0003075_altered_response_to | 0.75850227 |
| 105 | MP0000681_abnormal_thyroid_gland | 0.75673041 |
| 106 | MP0002090_abnormal_vision | 0.75412805 |
| 107 | MP0000516_abnormal_urinary_system | 0.75298426 |
| 108 | MP0005367_renal/urinary_system_phenotyp | 0.75298426 |
| 109 | MP0009764_decreased_sensitivity_to | 0.71487883 |
| 110 | MP0002693_abnormal_pancreas_physiology | 0.71470291 |
| 111 | MP0004808_abnormal_hematopoietic_stem | 0.70691565 |
| 112 | MP0006276_abnormal_autonomic_nervous | 0.70239869 |
| 113 | MP0005379_endocrine/exocrine_gland_phen | 0.70202338 |
| 114 | MP0003091_abnormal_cell_migration | 0.69437112 |
| 115 | MP0003279_aneurysm | 0.68904233 |
| 116 | MP0002295_abnormal_pulmonary_circulatio | 0.68621172 |
| 117 | MP0002095_abnormal_skin_pigmentation | 0.67144227 |
| 118 | MP0005397_hematopoietic_system_phenotyp | 0.66942810 |
| 119 | MP0001545_abnormal_hematopoietic_system | 0.66942810 |
| 120 | MP0000647_abnormal_sebaceous_gland | 0.66855809 |
| 121 | MP0002168_other_aberrant_phenotype | 0.66540529 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.66314214 |
| 123 | MP0003329_amyloid_beta_deposits | 0.65691074 |
| 124 | MP0000427_abnormal_hair_cycle | 0.65152770 |
| 125 | MP0003795_abnormal_bone_structure | 0.65007306 |
| 126 | MP0000490_abnormal_crypts_of | 0.64388087 |
| 127 | MP0003656_abnormal_erythrocyte_physiolo | 0.63390969 |
| 128 | MP0008004_abnormal_stomach_pH | 0.62905651 |
| 129 | MP0003690_abnormal_glial_cell | 0.62724707 |
| 130 | MP0003045_fibrosis | 0.61941224 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.57300596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.37461574 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.47116954 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.46003861 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.32126590 |
| 5 | Myositis (HP:0100614) | 3.95108872 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.92806082 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.41483767 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.35346033 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.28255214 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.21523258 |
| 11 | Optic neuritis (HP:0100653) | 3.21468549 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.21468549 |
| 13 | Orchitis (HP:0100796) | 3.12646104 |
| 14 | Obstructive lung disease (HP:0006536) | 3.11284163 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 3.11284163 |
| 16 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.95778724 |
| 17 | Disinhibition (HP:0000734) | 2.95626340 |
| 18 | Acute necrotizing encephalopathy (HP:0006965) | 2.90122438 |
| 19 | T lymphocytopenia (HP:0005403) | 2.89151295 |
| 20 | IgM deficiency (HP:0002850) | 2.88897325 |
| 21 | Abnormality of T cell number (HP:0011839) | 2.86072529 |
| 22 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.84264822 |
| 23 | Myocardial infarction (HP:0001658) | 2.75989300 |
| 24 | Tetraparesis (HP:0002273) | 2.75495674 |
| 25 | Subacute progressive viral hepatitis (HP:0006572) | 2.70721580 |
| 26 | Recurrent skin infections (HP:0001581) | 2.68805526 |
| 27 | Chronic otitis media (HP:0000389) | 2.67013125 |
| 28 | Progressive macrocephaly (HP:0004481) | 2.63980978 |
| 29 | Diminished motivation (HP:0000745) | 2.63950870 |
| 30 | Parakeratosis (HP:0001036) | 2.63788589 |
| 31 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.63015017 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58836299 |
| 33 | Urticaria (HP:0001025) | 2.58821694 |
| 34 | Mitochondrial inheritance (HP:0001427) | 2.57844759 |
| 35 | Amyotrophic lateral sclerosis (HP:0007354) | 2.57183750 |
| 36 | Mutism (HP:0002300) | 2.57165320 |
| 37 | Heterochromia iridis (HP:0001100) | 2.52938027 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.50627371 |
| 39 | Recurrent fungal infections (HP:0002841) | 2.47853215 |
| 40 | Stomatitis (HP:0010280) | 2.47686254 |
| 41 | Episodic fever (HP:0001954) | 2.46556089 |
| 42 | Pheochromocytoma (HP:0002666) | 2.45198906 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.44236646 |
| 44 | Exertional dyspnea (HP:0002875) | 2.43972232 |
| 45 | Chronic diarrhea (HP:0002028) | 2.42376761 |
| 46 | Apathy (HP:0000741) | 2.41045283 |
| 47 | Thyroid carcinoma (HP:0002890) | 2.39788143 |
| 48 | Papillary thyroid carcinoma (HP:0002895) | 2.39429573 |
| 49 | Vasculitis (HP:0002633) | 2.39052115 |
| 50 | Petechiae (HP:0000967) | 2.38306425 |
| 51 | Increased hepatocellular lipid droplets (HP:0006565) | 2.37152966 |
| 52 | Increased CSF protein (HP:0002922) | 2.33502385 |
| 53 | Arterial tortuosity (HP:0005116) | 2.32537561 |
| 54 | Limb dystonia (HP:0002451) | 2.31094633 |
| 55 | Abnormality of glycolipid metabolism (HP:0010969) | 2.31033105 |
| 56 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.31033105 |
| 57 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.31033105 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.29949646 |
| 59 | Prolonged bleeding time (HP:0003010) | 2.29612917 |
| 60 | Recurrent viral infections (HP:0004429) | 2.29429848 |
| 61 | Cerebral hemorrhage (HP:0001342) | 2.28672741 |
| 62 | Gingival bleeding (HP:0000225) | 2.28376896 |
| 63 | Hypothermia (HP:0002045) | 2.25958833 |
| 64 | Meningitis (HP:0001287) | 2.25872868 |
| 65 | Chest pain (HP:0100749) | 2.24918804 |
| 66 | Hypergammaglobulinemia (HP:0010702) | 2.24268115 |
| 67 | Increased IgM level (HP:0003496) | 2.23766353 |
| 68 | Hepatosplenomegaly (HP:0001433) | 2.23704968 |
| 69 | Papilledema (HP:0001085) | 2.22564156 |
| 70 | Hematochezia (HP:0002573) | 2.22143956 |
| 71 | Polyphagia (HP:0002591) | 2.21771865 |
| 72 | Increased serum pyruvate (HP:0003542) | 2.21428961 |
| 73 | Abnormality of glycolysis (HP:0004366) | 2.21428961 |
| 74 | Curly hair (HP:0002212) | 2.21157325 |
| 75 | Recurrent bronchitis (HP:0002837) | 2.17646720 |
| 76 | Vascular tortuosity (HP:0004948) | 2.16688580 |
| 77 | Agnosia (HP:0010524) | 2.15779331 |
| 78 | Recurrent pneumonia (HP:0006532) | 2.15380296 |
| 79 | Cellulitis (HP:0100658) | 2.13772681 |
| 80 | Orthostatic hypotension (HP:0001278) | 2.13064141 |
| 81 | Neuroendocrine neoplasm (HP:0100634) | 2.12877694 |
| 82 | Thrombocytosis (HP:0001894) | 2.11628485 |
| 83 | Pulmonary infiltrates (HP:0002113) | 2.09402651 |
| 84 | IgG deficiency (HP:0004315) | 2.08855879 |
| 85 | Leukocytosis (HP:0001974) | 2.08086723 |
| 86 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.06080570 |
| 87 | Poor head control (HP:0002421) | 2.05214814 |
| 88 | Abnormal platelet volume (HP:0011876) | 2.05008226 |
| 89 | Joint swelling (HP:0001386) | 2.02826152 |
| 90 | Amyloidosis (HP:0011034) | 2.02704743 |
| 91 | Bladder carcinoma (HP:0002862) | 2.01717306 |
| 92 | Bladder neoplasm (HP:0009725) | 2.01717306 |
| 93 | Muscle fibrillation (HP:0010546) | 2.01631772 |
| 94 | Osteomyelitis (HP:0002754) | 2.00178842 |
| 95 | Conjunctival hamartoma (HP:0100780) | 1.97880915 |
| 96 | Mucosal telangiectasiae (HP:0100579) | 1.96942229 |
| 97 | Hip dysplasia (HP:0001385) | 1.96653533 |
| 98 | Dysostosis multiplex (HP:0000943) | 1.96307928 |
| 99 | Progressive neurologic deterioration (HP:0002344) | 1.95638882 |
| 100 | Systemic lupus erythematosus (HP:0002725) | 1.95312590 |
| 101 | Thyroiditis (HP:0100646) | 1.95243245 |
| 102 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95200443 |
| 103 | Agitation (HP:0000713) | 1.94861024 |
| 104 | Gastrointestinal stroma tumor (HP:0100723) | 1.94528262 |
| 105 | Gastrointestinal infarctions (HP:0005244) | 1.93053228 |
| 106 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.91185258 |
| 107 | Encephalitis (HP:0002383) | 1.91119301 |
| 108 | Inappropriate behavior (HP:0000719) | 1.90916552 |
| 109 | Keratoconjunctivitis sicca (HP:0001097) | 1.90776737 |
| 110 | Xerostomia (HP:0000217) | 1.90445629 |
| 111 | Basal ganglia calcification (HP:0002135) | 1.88729717 |
| 112 | Gingivitis (HP:0000230) | 1.88148483 |
| 113 | Vertebral compression fractures (HP:0002953) | 1.87637350 |
| 114 | Autoimmune thrombocytopenia (HP:0001973) | 1.87587501 |
| 115 | Increased CSF lactate (HP:0002490) | 1.87440398 |
| 116 | Micronodular cirrhosis (HP:0001413) | 1.86779378 |
| 117 | Renal Fanconi syndrome (HP:0001994) | 1.86239636 |
| 118 | Glomerulopathy (HP:0100820) | 1.85407004 |
| 119 | Arterial thrombosis (HP:0004420) | 1.85389898 |
| 120 | Abnormality of binocular vision (HP:0011514) | 1.84640706 |
| 121 | Diplopia (HP:0000651) | 1.84640706 |
| 122 | Hepatocellular necrosis (HP:0001404) | 1.84374928 |
| 123 | Epistaxis (HP:0000421) | 1.83053218 |
| 124 | Recurrent lower respiratory tract infections (HP:0002783) | 1.82722159 |
| 125 | Lipid accumulation in hepatocytes (HP:0006561) | 1.82628449 |
| 126 | Increased mean platelet volume (HP:0011877) | 1.82446163 |
| 127 | Insidious onset (HP:0003587) | 1.79457736 |
| 128 | Termporal pattern (HP:0011008) | 1.79457736 |
| 129 | Recurrent cutaneous fungal infections (HP:0011370) | 1.78785216 |
| 130 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.78785216 |
| 131 | Abnormality of T cells (HP:0002843) | 1.78249200 |
| 132 | Pustule (HP:0200039) | 1.78222549 |
| 133 | Periodontitis (HP:0000704) | 1.78082187 |
| 134 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.77799782 |
| 135 | Pulmonary embolism (HP:0002204) | 1.77552402 |
| 136 | Loss of speech (HP:0002371) | 1.77243580 |
| 137 | Autoimmune hemolytic anemia (HP:0001890) | 1.76678276 |
| 138 | Hemoptysis (HP:0002105) | 1.76375215 |
| 139 | Chronic sinusitis (HP:0011109) | 1.74866596 |
| 140 | Tongue fasciculations (HP:0001308) | 1.74725276 |
| 141 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.74555847 |
| 142 | Amaurosis fugax (HP:0100576) | 1.74398997 |
| 143 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.73283757 |
| 144 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.73283757 |
| 145 | Fatigue (HP:0012378) | 1.73238632 |
| 146 | Albinism (HP:0001022) | 1.72589336 |
| 147 | Purpura (HP:0000979) | 1.72480951 |
| 148 | Keratoconjunctivitis (HP:0001096) | 1.71792825 |
| 149 | Cortical dysplasia (HP:0002539) | 1.71279051 |
| 150 | Abnormality of eosinophils (HP:0001879) | 1.69637595 |
| 151 | Abnormal hair whorl (HP:0010721) | 1.68942402 |
| 152 | Eosinophilia (HP:0001880) | 1.68551544 |
| 153 | Lymphopenia (HP:0001888) | 1.68306982 |
| 154 | Acute encephalopathy (HP:0006846) | 1.66327117 |
| 155 | Abnormality of the lumbar spine (HP:0100712) | 1.66239012 |
| 156 | Abnormality of the vocal cords (HP:0008777) | 1.65587970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 4.46655917 |
| 2 | TRIM28 | 3.86031879 |
| 3 | MST4 | 3.15348535 |
| 4 | RIPK4 | 2.67556208 |
| 5 | LIMK1 | 2.32810998 |
| 6 | BLK | 2.32667247 |
| 7 | IRAK4 | 2.20969193 |
| 8 | PIM2 | 2.06548710 |
| 9 | PBK | 1.97452570 |
| 10 | TESK2 | 1.95475760 |
| 11 | KIT | 1.93943041 |
| 12 | TXK | 1.91045425 |
| 13 | MAP4K1 | 1.82264192 |
| 14 | MAP3K14 | 1.82184502 |
| 15 | TBK1 | 1.81225554 |
| 16 | STK24 | 1.80985806 |
| 17 | ERBB3 | 1.80450803 |
| 18 | KSR1 | 1.77520578 |
| 19 | TESK1 | 1.75965113 |
| 20 | KDR | 1.69349394 |
| 21 | BCR | 1.67151919 |
| 22 | TGFBR2 | 1.61224494 |
| 23 | BMPR1B | 1.59896648 |
| 24 | ZAP70 | 1.58964097 |
| 25 | FER | 1.57506237 |
| 26 | JAK3 | 1.54251242 |
| 27 | PLK2 | 1.53943385 |
| 28 | GRK7 | 1.51046444 |
| 29 | SYK | 1.50007525 |
| 30 | TGFBR1 | 1.49345975 |
| 31 | FGR | 1.46462918 |
| 32 | TYK2 | 1.46073977 |
| 33 | FES | 1.42080988 |
| 34 | ARAF | 1.41086388 |
| 35 | TEC | 1.37870004 |
| 36 | MAP3K6 | 1.35039756 |
| 37 | MAP3K4 | 1.34775655 |
| 38 | CDK19 | 1.33767756 |
| 39 | NME2 | 1.30986232 |
| 40 | MYLK | 1.30813542 |
| 41 | SCYL2 | 1.29282670 |
| 42 | MAP3K2 | 1.26415863 |
| 43 | CSF1R | 1.25136093 |
| 44 | LRRK2 | 1.24949583 |
| 45 | ITK | 1.18578112 |
| 46 | BTK | 1.17818247 |
| 47 | BUB1 | 1.17533607 |
| 48 | SIK3 | 1.15006228 |
| 49 | LCK | 1.14107797 |
| 50 | BMPR2 | 1.10214676 |
| 51 | WNK3 | 1.08444099 |
| 52 | TSSK6 | 1.08110850 |
| 53 | PAK4 | 1.08064285 |
| 54 | EPHB1 | 1.06699727 |
| 55 | STK16 | 1.06086946 |
| 56 | EIF2AK1 | 1.01788660 |
| 57 | EPHA3 | 0.99805658 |
| 58 | CAMKK2 | 0.99448904 |
| 59 | CDK6 | 0.99116652 |
| 60 | LYN | 0.98654102 |
| 61 | EIF2AK3 | 0.98279420 |
| 62 | MAP3K5 | 0.97413686 |
| 63 | GRK6 | 0.97190189 |
| 64 | CSNK1G1 | 0.95074341 |
| 65 | PAK3 | 0.91852017 |
| 66 | DAPK1 | 0.90786912 |
| 67 | ADRBK2 | 0.89435822 |
| 68 | IKBKB | 0.87772419 |
| 69 | STK10 | 0.87320899 |
| 70 | DYRK2 | 0.86346471 |
| 71 | ACVR1B | 0.86106583 |
| 72 | MINK1 | 0.85847718 |
| 73 | JAK2 | 0.83111995 |
| 74 | ILK | 0.82855766 |
| 75 | MAP2K4 | 0.80873076 |
| 76 | MAPKAPK5 | 0.80096509 |
| 77 | IKBKE | 0.78350738 |
| 78 | CASK | 0.74971959 |
| 79 | CSNK1G3 | 0.74434134 |
| 80 | FGFR3 | 0.73825268 |
| 81 | HCK | 0.71587833 |
| 82 | TAOK3 | 0.69226766 |
| 83 | CLK1 | 0.67051564 |
| 84 | MAP3K1 | 0.66878337 |
| 85 | VRK1 | 0.66471738 |
| 86 | JAK1 | 0.66451701 |
| 87 | RPS6KA4 | 0.65353474 |
| 88 | CSK | 0.64891906 |
| 89 | MAP4K2 | 0.63669384 |
| 90 | YES1 | 0.62747157 |
| 91 | TNIK | 0.62115409 |
| 92 | GRK5 | 0.61820166 |
| 93 | MAP2K7 | 0.60713548 |
| 94 | NME1 | 0.60156268 |
| 95 | MOS | 0.59072171 |
| 96 | MAPK13 | 0.58981246 |
| 97 | ABL1 | 0.58781467 |
| 98 | FRK | 0.57716790 |
| 99 | PRKCD | 0.57581294 |
| 100 | MARK1 | 0.57358013 |
| 101 | CDK14 | 0.56660661 |
| 102 | MAP3K3 | 0.55505748 |
| 103 | PTK2B | 0.55092635 |
| 104 | MKNK2 | 0.53786446 |
| 105 | NEK9 | 0.53127686 |
| 106 | ABL2 | 0.52989648 |
| 107 | MAP3K13 | 0.52629441 |
| 108 | ROCK2 | 0.51183940 |
| 109 | CCNB1 | 0.51071503 |
| 110 | FYN | 0.48794762 |
| 111 | TRPM7 | 0.46442426 |
| 112 | MAPKAPK2 | 0.46306168 |
| 113 | MAP2K3 | 0.46190129 |
| 114 | ADRBK1 | 0.45382258 |
| 115 | EGFR | 0.45005019 |
| 116 | MATK | 0.43882400 |
| 117 | CSNK1G2 | 0.43364406 |
| 118 | TIE1 | 0.41259572 |
| 119 | CSNK1A1L | 0.41047194 |
| 120 | DAPK3 | 0.40252239 |
| 121 | OXSR1 | 0.40016994 |
| 122 | PRKCQ | 0.40005175 |
| 123 | INSR | 0.39938852 |
| 124 | PRKCE | 0.39589871 |
| 125 | STK38L | 0.38391664 |
| 126 | STK39 | 0.37881031 |
| 127 | IGF1R | 0.36807830 |
| 128 | IRAK1 | 0.32017546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.06887474 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.31211636 |
| 3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.17879111 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.13121082 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.05102360 |
| 6 | Phagosome_Homo sapiens_hsa04145 | 2.00660135 |
| 7 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.97974628 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.89060915 |
| 9 | Protein export_Homo sapiens_hsa03060 | 1.84730927 |
| 10 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.76789159 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 1.72925765 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.71604169 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.67343974 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.64743137 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60982294 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.60881814 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.58727174 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.53676658 |
| 19 | * Shigellosis_Homo sapiens_hsa05131 | 1.48719380 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.47611722 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47519377 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.45833063 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42920892 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.42732841 |
| 25 | Ribosome_Homo sapiens_hsa03010 | 1.42153063 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.41755636 |
| 27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.40720000 |
| 28 | * Salmonella infection_Homo sapiens_hsa05132 | 1.38883657 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.36397840 |
| 30 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.33001318 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28207049 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23829118 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.23707273 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22927234 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20505423 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.20319900 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20100000 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17088598 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16647179 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12466604 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11724345 |
| 42 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08066346 |
| 43 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.07078463 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.06597150 |
| 45 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04047015 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.02665353 |
| 47 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02352470 |
| 48 | Huntingtons disease_Homo sapiens_hsa05016 | 1.00742614 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00115953 |
| 50 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99399945 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98649195 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.95969443 |
| 53 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95167180 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95075724 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94938046 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 0.92278548 |
| 57 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.91346617 |
| 58 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87549235 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85477156 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83657013 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83180101 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 0.83029711 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82558353 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81386646 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 0.80622628 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.79759028 |
| 67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79130733 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79113774 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.78025317 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74529208 |
| 71 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73252954 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68323604 |
| 73 | * Endocytosis_Homo sapiens_hsa04144 | 0.68183707 |
| 74 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67375973 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65443818 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63388212 |
| 77 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62583938 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61109861 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59000379 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58781109 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58116279 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57691017 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56929753 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55790766 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.55774375 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.55420019 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54945929 |
| 88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54658967 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54578921 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50167194 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50164108 |
| 92 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49658208 |
| 93 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.48632501 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48289672 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.47205017 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.47162001 |
| 97 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.46802949 |
| 98 | * Pancreatic cancer_Homo sapiens_hsa05212 | 0.45781737 |
| 99 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44743261 |
| 100 | Long-term depression_Homo sapiens_hsa04730 | 0.43502726 |
| 101 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43009041 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42138222 |
| 103 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.40842636 |
| 104 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40598201 |
| 105 | Spliceosome_Homo sapiens_hsa03040 | 0.39249023 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36777542 |
| 107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36231440 |
| 108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35330888 |
| 109 | Morphine addiction_Homo sapiens_hsa05032 | 0.35168958 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34453491 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34239350 |
| 112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.33707633 |
| 113 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32566442 |
| 114 | GABAergic synapse_Homo sapiens_hsa04727 | 0.32308480 |
| 115 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32261201 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31398404 |
| 117 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31001002 |
| 118 | Alcoholism_Homo sapiens_hsa05034 | 0.30175886 |
| 119 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29410977 |
| 120 | Basal transcription factors_Homo sapiens_hsa03022 | 0.28818642 |

